ArticleScientific reports2024
Development of flame retardant slow release insecticides paint and testing its efficacy for four years against dengue and malaria vectors.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Insecticide based paint formulations have been available since years, however the concept of using such paint products at household level did not get attention due to various reasons. The advancement in insecticidal paint technology has steered toward the development and evaluation of such formulations for use against arthropod vectors. The improved insecticidal paint formulations may contain two or more active agents, hence could display different type of activity against the target vectors. In the present study, optimum concentrations of deltamethrin (1%), chlorpyriphos (0.5%) and pyriproxyfen (0.075%) were used as active ingredients (AIs) to develop flame retardant slow-release insecticides paint (FRSRIP) formulation. The developed formulation was tested for physico-chemical properties, toxicity and efficacy against two important mosquito vectors. The formulation was glossy, smooth, uniform and scratch proof. Furthermore, the formulation was flame retardant and conformed to class-A according to the guidelines. Acute oral, dermal and inhalation toxicity suggested that the formulation is safe for use in human dwellings. The formulation was evaluated against Ae. aegypti and An. stephensi mosquitoes in laboratory upto four years. It was found that KDT
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.